Artwork

Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Player FM - Aplicație Podcast
Treceți offline cu aplicația Player FM !

Discovery on Target 2018 | Engineering NK Cells for Enhanced Potency and Persistence

8:03
 
Distribuie
 

Manage episode 215058516 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism. For more information, please visit http://www.DiscoveryOnTarget.com/NK-Cell-Based-Cancer-Immunotherapy/
  continue reading

255 episoade

Artwork
iconDistribuie
 
Manage episode 215058516 series 31038
Content provided by CHI Podcasts and Cambridge Healthtech Podcasts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CHI Podcasts and Cambridge Healthtech Podcasts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
Dr. James Trager shares a preview of his talk at the NK cell-based cancer immunotherapy meeting in Boston, discusses his next step in research and the vision of Nkarta in NK cell therapy development and what he’s looking forward to at this meeting such as the topics of inhibition of MIC protein shedding and NK cell metabolism. For more information, please visit http://www.DiscoveryOnTarget.com/NK-Cell-Based-Cancer-Immunotherapy/
  continue reading

255 episoade

Toate episoadele

×
 
Loading …

Bun venit la Player FM!

Player FM scanează web-ul pentru podcast-uri de înaltă calitate pentru a vă putea bucura acum. Este cea mai bună aplicație pentru podcast și funcționează pe Android, iPhone și pe web. Înscrieți-vă pentru a sincroniza abonamentele pe toate dispozitivele.

 

Ghid rapid de referință